| Jennifer Kenyon, LCSW | |
|
3541 N Crossing Cir, Valdosta, GA 31602-1019 | |
| (229) 244-4200 | |
| (229) 244-4995 |
| Full Name | Jennifer Kenyon |
|---|---|
| Gender | Female |
| Speciality | Clinical Social Worker |
| Experience | 11 Years |
| Location | 3541 N Crossing Cir, Valdosta, Georgia |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1245640911 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | CSW005863 (Georgia) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Valdosta Psychiatric Associates, Llc | 6305832650 | 5 |
News Archive
Avila Therapeutics, Inc., a biotechnology company developing novel covalent drugs that treat diseases through protein silencing, presented results of preclinical studies on its highly selective, pan-genotype, small molecule Hepatitis C Virus (HCV) protease inhibitor, AVL-181.
APP Pharmaceuticals, Inc., a wholly owned subsidiary of Fresenius Kabi Pharmaceuticals Holding, Inc., (NASDAQ:APCVZ) announced today that it has received approval from the U.S. Food and Drug Administration (FDA) to market Deferoxamine Mesylate for Injection, USP, in two dosage strengths. Deferoxamine Mesylate is therapeutically equivalent to the reference-listed drug Desferal®, which is marketed by the innovator Novartis.
People who engage in activities that exercise the brain, such as reading, writing, and playing card games, may delay the rapid memory decline that occurs if they later develop dementia, according to a study published in the August 4, 2009, print issue of Neurology, the medical journal of the American Academy of Neurology.
Following a Priority Review, Health Canada has approved Prevnar 13 (Pneumococcal 13-valent Conjugate Vaccine (Diphtheria CRM197 Protein)) for children aged six weeks through five years for active immunization against invasive pneumococcal disease, a bacterial infection that can include meningitis (inflammation of the coverings of the brain and spinal cord), sepsis (bloodstream infection), bacteremic pneumonia, pleural empyema (accumulation of pus in the cavity surrounding the lungs) and bacteremia (bacteria in the blood).
A National Institutes of Health network study provided the first conclusive evidence that treating pregnant women who have even the mildest form of gestational diabetes can reduce the risk of common birth complications among infants, as well as blood pressure disorders among mothers.
› Verified 1 days ago
| Entity Name | Valdosta Psychiatric Associates, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1336282144 PECOS PAC ID: 6305832650 Enrollment ID: O20040422000175 |
News Archive
Avila Therapeutics, Inc., a biotechnology company developing novel covalent drugs that treat diseases through protein silencing, presented results of preclinical studies on its highly selective, pan-genotype, small molecule Hepatitis C Virus (HCV) protease inhibitor, AVL-181.
APP Pharmaceuticals, Inc., a wholly owned subsidiary of Fresenius Kabi Pharmaceuticals Holding, Inc., (NASDAQ:APCVZ) announced today that it has received approval from the U.S. Food and Drug Administration (FDA) to market Deferoxamine Mesylate for Injection, USP, in two dosage strengths. Deferoxamine Mesylate is therapeutically equivalent to the reference-listed drug Desferal®, which is marketed by the innovator Novartis.
People who engage in activities that exercise the brain, such as reading, writing, and playing card games, may delay the rapid memory decline that occurs if they later develop dementia, according to a study published in the August 4, 2009, print issue of Neurology, the medical journal of the American Academy of Neurology.
Following a Priority Review, Health Canada has approved Prevnar 13 (Pneumococcal 13-valent Conjugate Vaccine (Diphtheria CRM197 Protein)) for children aged six weeks through five years for active immunization against invasive pneumococcal disease, a bacterial infection that can include meningitis (inflammation of the coverings of the brain and spinal cord), sepsis (bloodstream infection), bacteremic pneumonia, pleural empyema (accumulation of pus in the cavity surrounding the lungs) and bacteremia (bacteria in the blood).
A National Institutes of Health network study provided the first conclusive evidence that treating pregnant women who have even the mildest form of gestational diabetes can reduce the risk of common birth complications among infants, as well as blood pressure disorders among mothers.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jennifer Kenyon, LCSW 5277 Cypress Dr, Lake Park, GA 31636-3143 Ph: (229) 460-7846 | Jennifer Kenyon, LCSW 3541 N Crossing Cir, Valdosta, GA 31602-1019 Ph: (229) 244-4200 |
News Archive
Avila Therapeutics, Inc., a biotechnology company developing novel covalent drugs that treat diseases through protein silencing, presented results of preclinical studies on its highly selective, pan-genotype, small molecule Hepatitis C Virus (HCV) protease inhibitor, AVL-181.
APP Pharmaceuticals, Inc., a wholly owned subsidiary of Fresenius Kabi Pharmaceuticals Holding, Inc., (NASDAQ:APCVZ) announced today that it has received approval from the U.S. Food and Drug Administration (FDA) to market Deferoxamine Mesylate for Injection, USP, in two dosage strengths. Deferoxamine Mesylate is therapeutically equivalent to the reference-listed drug Desferal®, which is marketed by the innovator Novartis.
People who engage in activities that exercise the brain, such as reading, writing, and playing card games, may delay the rapid memory decline that occurs if they later develop dementia, according to a study published in the August 4, 2009, print issue of Neurology, the medical journal of the American Academy of Neurology.
Following a Priority Review, Health Canada has approved Prevnar 13 (Pneumococcal 13-valent Conjugate Vaccine (Diphtheria CRM197 Protein)) for children aged six weeks through five years for active immunization against invasive pneumococcal disease, a bacterial infection that can include meningitis (inflammation of the coverings of the brain and spinal cord), sepsis (bloodstream infection), bacteremic pneumonia, pleural empyema (accumulation of pus in the cavity surrounding the lungs) and bacteremia (bacteria in the blood).
A National Institutes of Health network study provided the first conclusive evidence that treating pregnant women who have even the mildest form of gestational diabetes can reduce the risk of common birth complications among infants, as well as blood pressure disorders among mothers.
› Verified 1 days ago
Ms. Barbara Faye Frier, LCSW Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 3541 Northcrossing Cir, Valdosta, GA 31602 Phone: 229-244-4200 | |
Mary Fulp-pye, LCSW Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 3541 N Crossing Cir, Valdosta, GA 31602 Phone: 229-244-4200 Fax: 229-244-4995 | |
Lyndi Nicole Farnam, LCSW Clinical Social Worker Medicare: May Accept Medicare Assignments Practice Location: 2109 N Patterson St Ste B, Valdosta, GA 31602 Phone: 229-232-4833 Fax: 877-343-0538 | |
Kelly Delayne Jones, LCSW Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 2310 N Patterson St, Suite G, Valdosta, GA 31602 Phone: 229-244-9688 Fax: 229-244-5354 | |
Ms. Jayne Deon Hodges-wade, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 2935 N Ashley St, Building F, Valdosta, GA 31602 Phone: 229-333-2273 Fax: 229-293-7911 | |
Latasha Yvette Alston, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 2529 Forrestwood Dr, Valdosta, GA 31602 Phone: 229-630-8097 | |
Mr. Charles Coker, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 781 Lake Laurie Dr., Valdosta, GA 31605 Phone: 706-809-4931 |